Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Sepsis Therapeutics
... at a CAGR of 6.5% over the analysis period 2023-2030. Cephalosporin Drugs, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$3.0 Billion by the end of ... Read More
-
Acute Myeloid Leukemia (AML) Therapeutics
... is expected to reach US$1.7 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2023-2030. Cytarabine, one of the segments analyzed in the report, is expected to record a 15.5% CAGR ... Read More
-
ADME-Toxicology Testing
... at a CAGR of 10.9% over the analysis period 2023-2030. Cell Culture Technology, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$9.6 Billion by the end ... Read More
-
Global Osteoporosis Drugs Market Report by Route of Administration (Injectable, Oral, Others) Product Type (Rank Ligand Inhibitor, Bisphosphonates, Calcitonin, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Sclerostin Inhibitor, Others) Countries and Company Analysis, 2024-2032
... 2024-2032 Osteoporosis Drugs Market Analysis The osteoporosis drugs market is expected to over US$ 25.53 billion by 2032 from US$ 17.43 billion by 2023, with a CAGR growth of 4.33% from 2024 to 2032 because ... Read More
-
United States Pain Management Therapeutics Market and Forecast Therapeutics (Devices and Pharmaceuticals), Pain Type, Drug Class, Indication, Distribution Channel and Company Analysis 2024-2032
... Therapeutics Market will reach US$ 36.15 billion by 2032, up from US$ 26.18 billion in 2023, with a CAGR of 3.65% between 2024 and 2032. Many factors are driving the market's rapid expansion such as ... Read More
-
Cystic Fibrosis Therapeutics
... by 2030, growing at a CAGR of 15.1% over the analysis period 2023-2030. Cystic Fibrosis Medication, one of the segments analyzed in the report, is expected to record a 15.5% CAGR and reach US$42.1 Billion ... Read More
-
Peripheral Arterial Disease (PAD) Therapeutics
... is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.8% ... Read More
-
Global Antacids Market Report by Formulation Type (Powder, Tablets, Liquid, Others) Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) Drug Class (Acid Neutralizers, Proton Pump Inhibitors, H2 Antagonist, Pro-Motility Agents) Countries and Company Analysis, 2024-2032
... Global Antacids Market Size Global antacids Market will be expected to cross US$ 9.70 billion by 2032 with a CAGR of 3.89 from 2024 to 2032. This growth has been fostered by the rising incidence ... Read More
-
Epigenetics
... of 13.3% over the analysis period 2023-2030. Epigenetics Kits, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$1.9 Billion by the end of the analysis period. ... Read More
-
Women's Health Therapeutics
... Billion by 2030, growing at a CAGR of 12.7% over the analysis period 2023-2030. Postmenopausal Osteoporosis Application, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$18.1 ... Read More
-
Lung Cancer Therapeutics
... by 2030, growing at a CAGR of 10.9% over the analysis period 2023-2030. Non-Small-Cell Lung Cancer (NSCLC) Therapeutics, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach ... Read More
-
Botulinum Toxin
... at a CAGR of 8.8% over the analysis period 2023-2030. Type A Botulinum Toxin, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$11.0 Billion by the ... Read More
-
Global AI in Drug Discovery Market 2024-2031
... and others), by Application (Drug Optimization and Repurposing, Preclinical Testing and Drug Screening) and by End-Users (Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs) and Research Centers and Academic & Government Institutes), Forecast Period (2024-2031) ... Read More
-
Enzyme Contract Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Enzymes [Pharmaceutical Manufacturing, Diagnostic, Research And Development, And Others]) and geography is expected to grow at a steady CAGR forecast till 2030 owing to the growing pharmaceutical and healthcare sector and the product development activities ... Read More
-
Ophthalmic Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Drug Class (Anti-Allergic, Anti-Inflammatory, Anti-Vegf Agents, And Others), By Dosage Forms (Gels, Capsules/Tablets, Eye Drops, And Others), and by geography is expected to advance at a respectable cagr forecast till 2030 owing to the rising ... Read More
-
Keratoconus - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Keratoconus: Understanding ... Read More
-
Metabolomics
... of 14.4% over the analysis period 2023-2030. Biomarker Discovery Application, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Mydriasis - Market Insight, Epidemiology And Market Forecast - 2034
... coming years due to the increasing prevalence of NMIBC, the launch of high-priced therapies, and the rising number of active companies in this field. Among all risks, high-risk NMIBC accounted for the highest market size ... Read More
-
Neurotrophic Keratitis Market Insight, Epidemiology And Market Forecast - 2034
... to ankylosis. Disease pathogenesis depends on genetic, immunological, mechanical, and bioenvironmental factors. HLA-B27 represents the most important genetic factor (other relevant genes include genes encoding interleukin-23 receptor and endoplasmatic reticulum aminopeptidase 1-ERAP1), although the disease ... Read More
-
Mydriasis - Epidemiology Forecast - 2034
... Out of the total surgeries, cataract surgery accounted for the highest with nearly 920 thousand cases. These cases are expected to change during the study period. Total eye examinations and surgery accounted for nearly 352 ... Read More
-
Hair Loss Treatment & Removal in the US - Industry Market Research Report
... treatments that address many hair-care needs. Over the past five years, the industry has experienced strong growth due to the increasing popularity of industry services. In fact, industry revenue has been increasing at a CAGR ... Read More
-
Metabolomics Market (Product and Service Type: Metabolomic Instruments, and Bioinformatics Tools and Services; and Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Personalized Medicine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Forecast, 2024-2034 Metabolomics Market – Scope of Report TMR’s report on the global metabolomics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of ... Read More
-
Europe Synthetic Hormones Market: Focus on Product Type, Route of Administration, Application, End User, and Country - Analysis and Forecast, 2023-2033
... at $4.90 billion in 2023 and is expected to reach $10.53 billion by 2033, growing at a CAGR of 7.94% during the forecast period 2023-2033. The synthetic hormones market is advancing due to significant developments ... Read More
-
Europe Highly Potent API Market - Analysis and Forecast, 2023-2033
... 2023, growing at a CAGR of 10.57% during the forecast period 2023-2033. The primary factors propelling the expansion of the highly potent API market are the rising incidence of cancer, which boosts the demand for ... Read More
-
Prurigo Nodularis: Competitive Landscape
... PN are anticipated in the 16 countries covered in GlobalData’s epidemiology forecast for PN. There is only a single disease-modifying innovator therapy available in the market for PN. The PN pipeline comprises 20 molecules, with ... Read More
Research Assistance
